RT Journal Article
SR Electronic
T1 Partitioning and probe-based quantitative PCR assays for the wastewater monitoring of Mycobacterium tuberculosis Complex, M. tuberculosis, and M. Bovis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.12.18.24319238
DO 10.1101/2024.12.18.24319238
A1 Nguyen, Tram B.
A1 Mercier, Elisabeth
A1 Wong, Chandler H.
A1 Hegazy, Nada
A1 Kabir, Md Pervez
A1 Tomalty, Emma
A1 Addo, Felix
A1 Ward, Leonor
A1 Renouf, Elizabeth
A1 Wan, Shen
A1 Tcholakov, Yassen
A1 Guilherme, Stéphanie
A1 Delatolla, Robert
YR 2024
UL http://medrxiv.org/content/early/2024/12/18/2024.12.18.24319238.abstract
AB Three new probe-based quantitative PCR assays were designed based on Chae et al. (2017), Pérez-Osorio et al. (2012), and Sales et al. (2012) to quantitate Mycobacterium tuberculosis complex (MTBC) species, M. tuberculosis (MTB), and M. bovis (MB) in wastewater targeting genomic regions rv0577, RD9, and the deletion of RD4, respectively. The assays were validated for specificity using four Mycobacterial species, including two MTBC species and two non-tuberculosis Mycobacteria species, and endogenous wastewater samples from Ottawa, Ontario, Canada, Mumbai, India, and a remote Northern Indigenous community in Nunangat with known ongoing tuberculosis cases or outbreaks. The three assays demonstrate high sensitivity and are suitable for use in wastewater. Partitioning experiments performed on endogenous MTBC and MTB in collected wastewaters from Mumbai, India with known tuberculosis outbreaks show that the targeted genomic regions of rv0577 (MTBC) and RD9 (MTB) used to quantitate human tuberculosis infection predominately partition to solids fraction of wastewaters. The partitioning results of this study, in combination with the presented probe-based PCR assays, provide guidance on how to best enrich wastewaters and rapidly and economically quantify tuberculosis with high specificity and sensitivity in wastewaters.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the CIHR Applied Public Health Research Chair in Environment, Climate Change and One Health, awarded to Dr. Robert Delatolla. The funding had no involvement in the study design, data collection, data analysis, data interpretation, nor the writing or decision to submit the paper for publication. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used only openly available human data that were originally located at: https://www.publichealthontario.ca/-/media/Documents/T/24/tuberculosis-ontario-epi-summary-2019-2023.pdf?rev=c6ff541604bd4e6491aa7cbb97944439&sc_lang=en https://doi.org/10.3389/FTUBR.2024.1454277 https://nunatsiaq.com/stories/article/nunavik-health-board-says-tuberculosis-present-in-8-communities/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData will be available upon reasonable request by contacting the corresponding author.